Garmin may soon monitor blood sugar in its smartwatch. The brand, which focuses on intensive fitness and health tracking with its premium smartwatch Prasad, recently published a patent with the US Patent Office. According to reports, while the patent mainly focuses on exercise data analysis, it also includes a surprise: a roadmap for non-invasive glucose tracking using wearable equipment.

Although the patent not only exposes the monitoring of the blood sugar, the germin has allegedly underlined a technical strong method, which in principle, can allow its smartwatch to estimate glywacked hemoglobin levels-usually known as HBA 1C-Using to evaluate long-term blood glucose.

According to a report by Gadgets and Wearbals, there is a technique called pulse spectrometry in the center of the proposal of gamin, which uses light to detect chemical changes under the skin. This idea is relatively simple: the wearable light will shine-especially in the near-late border-in the skin, then grab how the light is absorbed and reflected by tissue and blood. Since glucose affects how lighting interacts with biological structures, measuring subtle variations in these optical signals may be able to estimate glucose levels.

The patent allegedly describes details about a network of emitter and sensors, tuned for each specific wavelength, working together to interpret these differences. While smartwatches already use photoplethicography (PPG) to monitor heart rate and blood oxygen, gamin patent suggests a better approach-analyzing multi-virtuous PPG indications to achieve a better approach-oxygen-containing, deoxinated and glycified hemoglobin.

It is worth noting that the patent of gardene does not focus on real -time glucose readings such as current continuous glucose is introduced by the monitor (CGM). Instead, its purpose is to estimate HBA1C – a metric doctors use to assess a average blood sugar level in two to three months. This reading is important because HBA1C is not affected by short -term factors such as food or exercise. Instead, it provides a more stable picture of metabolic health – a healthcare that depends on the diagnosis and management of conditions such as the healthcare professional type 1 and type 2 diabetes.

If germina manages to bring this technique into its smartwatch, it may mean that users can get a new set of health matrix – which is getting the HBA1C score on your wrist, updated over time, without a lab visit. For anyone concerned about diabetes or simply monitoring long -term health, such characteristic will be both revolutionary and convenient but convenient.

However, it is important to note that the technique is still part of a patent. Companies like Apple and Samsung have also filed several patents for non-invasive glucose monitoring, but so far no one has provided the facility to work in the market. Nevertheless, it suggests that Garmin is seriously considering bringing this multi-discussion and high anticipated health tracker for its future smartwatch.